News from Portfolio Companies

New Ventures News and Publications

  • Alán Aspuru-Guzik and the Revolution in Molecular Design
    Summary Harry gets an update on the merger of AI, robotics, and high-throughput chemistry in the new “self-driving laboratory” from University of Toronto theoretical chemist Alán Aspuru-Guzik. Episode Notes Many of the processes carried out in traditional chemistry labs searching for new drugs or drug targets can be sped up through factory-style automation—and in fact, “combinatorial chemistry” was a big ...
  • Jennifer Carter and the Power of Individualized Cancer Care
    SHOW NOTES Dr. Jennifer Carter says it was watching friends and family members stricken with cancer struggle navigate the complexities of the healthcare system in the early 2000s that inspired her to start a company in the area of precision medicine. At that time, the development of targeted therapies for cancers with specific genetic markers was already offering new hope ...
  • Aalpen Patel and Using AI to Reduce Time-to-Diagnosis (AI World Special Series Part 1)
    EPISODE SUMMARY: What if we could use machine learning to train software to read CT scans of patients with intracranial hemorrhaging? Time to diagnosis could be doubled, potentially saving lives. This week Harry discusses such questions with Dr. Aalpen Patel, a physician-engineer who chairs Geisinger’s department of radiology and directs is 3D imaging and printing laboratory. This episode is the ...
  • Massimo Buscema on AI and What We Can and Can’t See in the Human Body
    Episode Summary: Harry’s guest in this episode is Massimo Buscema, director of the Semeion Research Center in Rome, Italy, and a full professor at the University of Colorado at Denver. Buscema researches and consults internationally on the theory and applications of AI, artificial neural networks, and evolutionary algorithms. The conversation focuses on AI and its applications in healthcare, and how ...
  • AI World Series – Aalpen Patel from Geisinger and Sandy Aronson from Partners Healthcare talk Implementation of AI tools for Providers
    Episode Summary: What if we could use machine learning to train software to read CT scans of patients with intracranial hemorrhaging? Time to diagnosis could be doubled, potentially saving lives. This week Harry discusses such questions with Dr. Aalpen Patel, a physician-engineer who chairs Geisinger’s department of radiology and directs is 3D imaging and printing laboratory. This episode is the ...
  • Barrett Rollins and The Reality of Precision Medicine
    For nearly a decade, the idea of “Precision Medicine” or similar variations like “Personalized Medicine” has been touted as the penultimate achievement of the Human Genome Project. Conceptually, this makes sense: once we figured out the DNA sequence, it stood to reason that we would be able to find the mutations that cause disease and develop therapeutics targeted to those ...
  • Barrett Rollins and the DNA-driven Transformation of Oncology
    EPISODE SUMMARY: Harry’s guest for this episode is Dr. Barrett Rollins, the chief scientific officer and faculty dean for academic affairs at Boston’s Dana Farber Cancer Institute and the Linde Family Professor of Medicine at Harvard Medical School. Harry and Dr. Rollins dig into how large-scale DNA analysis can one day put much more usable information into the hands of ...
  • Robert Green on the Impact of Individual Genomic Data
    Episode Summary: Harry’s guest this week, Dr. Robert Green, is a professor of medicine and genetics at Harvard Medical School and director of the Genomes To People research program at Brigham & Women’s Hospital and the Broad Institute of Harvard and MIT. They dig into the individual genome, how genomic data is being used, and the impact of genomics on ...
  • How will AI/ML Driven Image Analytics change the future of Neuroimaging?
    Episode Summary: Harry talks with Wim Van Hecke, the founder and CEO of Icometrix—builder of a cloud-based AI platform for analyzing brain MRI and CT scans—to find out how the startup’s FDA-cleared technology is changing the way radiologists and other physicians interpret neuroimaging data. About Harry: Harry Glorikian is an influential global business expert with more than three decades of ...
  • Joel Dudley and What Happens When You Let Data–Not Hypotheses–Drive Discovery
    Episode Summary: Harry’s guest this week is Dr. Joel Dudley from the Icahn School of Medicine at Mount Sinai, where he serves as executive vice president of precision health, associate professor of genetics and genomic sciences, and founding director of the Institute for Next Generation Healthcare. Dr. Dudley explains how his group is utilizing data to uncover health problems that ...